Andres Salumets (co-principal investigator of the cGEM project) is a professor of reproductive medicine at the Institute of Clinical Medicine at UT and visiting professor of University of Helsinki, Finland. Professor Salumets and his team have studied the etiopathogenesis and genetic predisposition of several reproductive diseases with an aim to provide personalised medicine tool, including polygenic risk scores, for more precise diagnostics and treatment of reproductive diseases. His team has also developed non-invasive genetic testing technologies, focusing on the use of cell-free DNA (cfDNA) in prenatal diagnostics and oncology. At present, his research has also expanded to the use of non-invasive epigenetic markers for disease diagnosis. Professor Salumets has published about 150 publications, which have been cited according to WoS >2,000 times and his h-index is 24. He and his team has published collaborative papers in several outstanding journals, including Nature, Nature Genetics, Genome Biology, Human Molecular Genetics, Human Reproduction Update and Trends in Endocrinology and Metabolism. He has supervised seven completed doctoral theses and is currently supervising 15 doctoral students. In addition, Professor Salumets is the scientific director of the Competence Centre on Health Technology (CCHT), a UT co-owned research and technology organization that develops non-invasive genomic technologies. Professor Salumets is the co-inventor for three patent applications and for one patent. Three of his inventions are related to non-invasive genomic technologies, and a patent is related to medical genetic diagnostics.
.png "Facebook")
.png "In")
.png "pr")
